On April 20th, the "2025 Shanghai Jiao Tong University Entrepreneur Conference (AI Special Session)," hosted by Shanghai Jiao Tong University and co-organized by SJTU Hanyuan Asset Management, the Alumni Association Office, the School of Artificial Intelligence, and the SJTU Institute of Technology, with the assistance of Futeng Capital, was held at the School of Artificial Intelligence, Shanghai Jiao Tong University. Zhiyao Yuanchuang Medical Technology (Shanghai) Co., Ltd. stood out during this themed week event and won the "Future Star" enterprise award from Shanghai Jiao Tong University. This honor signifies that the company's technological strength and innovative achievements in empowering pharmaceutical R&D with artificial intelligence have gained high recognition from top universities and the industry-academia-research community.

PharmaInnovation, an AI-driven pharmaceutical company founded by researchers from Shanghai Jiao Tong University, is a "leader" in protein drug design technology. Since its establishment in November 2023, PharmaInnovation has rapidly risen to prominence. It has collaborated with Nobel Prize-winning protein design team members, inventors of the RFDiffusion method for protein backbone design, and co-founders of internationally renowned protein design companies such as Xaria, to release the protein design algorithm evaluation platform MotifBench. PharmaInnovation has established a proprietary, end-to-end, graphical, one-click generation platform for AI-driven protein drug design. It has also partnered with numerous domestic and international listed pharmaceutical companies to accelerate protein drug development services and has developed seven proprietary protein drug pipelines.

In the golden age of artificial intelligence reshaping life sciences, Zhiyao Yuanchuang is moving forward steadily, anchored by technological innovation and in collaboration with top academic forces.